Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Bladder cancer | R-HSA-9700206 | map05219 | PHA-00851261E | None | drug-path |
Vascular smooth muscle contraction | R-HSA-445355 | map04270 | PHA-00851261E | None | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | PHA-00851261E | None | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | PHA-00851261E | None | drug-path |
Long-term potentiation | R-HSA-9620244 | map04720 | PHA-00851261E | None | drug-path |
Non-homologous end-joining | R-HSA-5693571 | map03450 | PHA-00851261E | None | drug-path |
Gap junction | R-HSA-190861 | map04540 | PHA-00851261E | None | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | PHA-00851261E | None | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | metamizole sodium | 2230 | drug-path |
Melanoma | Q9UHD0-PRO_0000015379 | map05218 | metamizole sodium | 2230 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | metamizole sodium | 2230 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | metamizole sodium | 2230 | drug-path |
Taste transduction | R-HSA-162582 | map04742 | metamizole sodium | 2230 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | metamizole sodium | 2230 | drug-path |
ECM-receptor interaction | R-HSA-373711 | map04512 | metamizole sodium | 2230 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | metamizole sodium | 2230 | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | metamizole sodium | 2230 | drug-path |
Proteasome | R-HSA-68819 | map03050 | metamizole sodium | 2230 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | citiolone | 14520 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | citiolone | 14520 | drug-path |